LetPub Scientific Journal Selector (2018-2021), LANCET NEUROLOGY published in 2002, ENGLAND.

The Lancet Respiratory Medicine is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal is the global leader for essential original research in critical care and respiratory medicine, and delivers expert review, candid commentary, and

99%. Self-Citation Ratio (2019-2020) 2.00%. Official Website. http://www.thelancet.com/journals/laneur/issue/current. Online Manuscript Submission.

ISSN: 1078-8956. The Lancet Respiratory Medicine is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal is the global leader for essential original research in critical care and respiratory medicine, and delivers expert review, candid commentary, and Behavioural Neurology provides a platform for researchers and clinicians working in the areas of cognitive neuroscience, neuropsychology, and neuropsychiatry. The Lancet NeurologyAcceptance Rate.

All original research Articles judged eligible for consideration by the journal's staff will be peer-reviewed within 72 h and, if accepted, published in 4-8 weeks. All av L Neurol · 2016 · Citerat av 4 — Pointing the way to primary prevention of dementia.

Explore the current issue of The Lancet Neurology, a monthly journal covering international issues relevant to neurologists worldwide Skip to Main Content Login to your account

43 75 procent av patienterna blir helt återställda eller bara får dras med mildare biverkningar: Josep Dalmau Lancet Neurology, 2005. Sanchez, M et al, 2011.

The Lancet Respiratory Medicine is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal is the global leader for essential original research in critical care and respiratory medicine, and delivers expert review, candid commentary, and

Official Website: LANCET NEUROLOGY.

editorialmanager.com/thelancetneurology • Simply log on to EM and follow the onscreen instructions for all submissions The Lancet Neurology: journal: 11.258 Q1: 280: 275: 917: 5477: 8110: 270: 28.56: 19.92: 2: Acta Neuropathologica: journal: 8.158 Q1: 158: 153: 412: 9986: 6126: 327: 14.05: 65.27: 3: Alzheimer's and Dementia: journal: 6.012 Q1: 107: 166: 424: 7569: 5508: 394: 14.48: 45.60: 4: Brain: journal: 5.408 Q1: 325: 421: 1147: 16874: 8701: 750: 10.75: 40.08: 5: Nature Reviews Neurology: journal: 5.247 Q1: 139: 181: 516: 8419: 4045: 293: 14.53: 46.51: 6: Annals of Neurology The Lancet Neurology: Lancet Publishing Group: Scopus: 11.258: Q1: United Kingdom: 275: data not available, help us to fill out data not available, help us to fill out data not available, help us to fill out 31 The Lancet Neurology 28.755 【 IF History 】【 Acceptance Rate 】【 Review Speed 】 32 Nature Methods 28.467 【 IF History 】【 Acceptance Rate 】【 Review Speed 】 Acceptance rate: 5% Publication Frequency: Not provided: Publication Languages: English; Journal links neurology: 22703: spine: 22585: brain: 20015: neuro-oncology: 18795: journal of the neurological sciences: 17571: lancet neurology: 17211: neurosurgery: 16778: pain: 16734: neuroscientist: 16319 The three established speciality journals (The Lancet Neurology, The Lancet Oncology, and The Lancet Infectious Diseases) have built up strong reputations in their medical speciality. According to the Journal Citation Reports , The Lancet Oncology has a 2017 impact factor of 36.421, The Lancet Neurology has 27.144, and The Lancet Infectious Diseases has 25.148. [5] To see more details about The Lancet Neurology, Subscribe Now! Impact Factor JCR Categories/Rank Circulation Electronic Circulation Submission to Acceptance Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines The Lancet Neurology template will format your research paper to Elsevier's guidelines. Download your paper in Word & LaTeX, export citation & endnote styles, find journal impact factors, acceptance rates, and more.
Hogskola sjukskoterska

The use of heparin declined at a similar rate in all types of hospital settings, in stroke units vs nonstroke Type of department on hospital admission (medicine, neurology, geriatrics/rehabilitation, or other Lancet Neurol. Selumetinib recommended for approval in the EU by CHMP as the first medicine for The trial showed selumetinib demonstrated an objective response rate (ORR) of 66% (33 of 50 patients, The Lancet Neurology. 2014 Encephalitis”, Lancet Neurology 10 (2011): 63–74. 43 75 procent av patienterna blir helt återställda eller bara får dras med mildare biverkningar: Josep Dalmau Lancet Neurology, 2005. Sanchez, M et al, 2011.

Read the latest articles of The Lancet Neurology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature Elsevier.com visitor survey. We are always looking for ways to improve customer experience on Elsevier.com. We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit. If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Bvc tabelund

The use of heparin declined at a similar rate in all types of hospital settings, in stroke units vs nonstroke Type of department on hospital admission (medicine, neurology, geriatrics/rehabilitation, or other Lancet Neurol.

11C-PE2I and 18F-Dopa PET for assessing progression rate in Parkinson's: av M Reinholdsson · 2018 · Citerat av 30 — cost-efficient method to increase health in individuals of all ages, physical inactivity is a Stroke severity at hospital admittance was assessed with the. National Institutes of Lancet Neurol 2006;5: 603–612. 15. Lindley RI Lancet neurology - 2011-01-01. A Swedish national post-marketing surveillance study of natalizumab treatment in multiple. sclerosis. Carolina Holmén, Fredrik Its rapid assessment of service delivery for mental, neurological and substance use to COVID-19 and higher rates of death associated with the disease (11–13).